查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1587834

合成生物学市场规模、份额、趋势分析报告：2025-2030 年按产品、技术、应用、最终用途、地区和细分市场进行的预测

Synthetic Biology Market Size, Share & Trends Analysis Report By Product (Enzymes, Cloning Technologies Kits), By Technology (PCR, NGS), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

合成生物学市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球合成生物学市场规模将达到420.6亿美元，2025年至2030年复合年增长率为17.30%。

支持疫苗研究的政府和私人资金的存在以及临床试验中强大的产品平臺是市场的关键驱动力。合成生物製程在生产用于疾病鑑定的抗原和诊断剂、加速疫苗开发以及提高疫苗的整体性能和产量方面具有决定性的优势。

此外，政府机构的支持和多个项目的存在正在推动市场成长。例如，在美国，COVID-19 疫苗的研发、製造、监管和采购由联邦机构负责，包括生物医学高级研究与开发局 (BARDA)、国立卫生研究院 (NIH)、国防部、 FDA 等（先前的OWS）得到机构合作的大力支持。

纺织和营养等行业需求的增加等其他因素也促进了市场的成长。在合成生物学的帮助下，已经确定了几种最佳的食品生产流程。此外，合成生物学预计将有助于提高农业产量并发展害虫防治。预计它将有助于提高食品产量和害虫防治管理。

COVID-19 大流行预计将对市场成长产生积极影响。美国卫生研究院称讚合成生物学是加速疫苗开发的方法。因此，合成生物学实验室和公司正在积极利用这项技术来对抗 COVID-19 大流行。因此，在大流行期间，这些技术的使用预计会增加。

对个人化医疗的需求不断增长预计将成为未来几年市场成长的主要动力。设计用作治疗剂的新型蛋白质的使用例证了医学领域的合成生物学。这些蛋白质的设计对蛋白质结构进行了一些修改，以获得治疗所需的所需特性。例如，研究人员正在开发在胃肠道中稳定且可口服治疗苯酮尿症 (PKU) 的候选治疗酶。

另一方面，合成生物学引起了有关生物安保和生物安全的一些担忧。接触这些产品可能会对公共卫生和环境造成未知的风险。为了防止此类问题，欧洲、美洲和亚洲国家正在製定政策来管理合成生物学技术在基础和应用研究中的应用。

合成生物市场报告亮点

  • 从技术角度来看，PCR领域占据了最大的市场份额。这是因为现代生命科学正在加速发展，PCR技术在医学研究、病毒检测、食品饮料产业等许多领域中广泛应用。
  • 预计基因组编辑领域将在预测期内稳定成长。这使得研究人员能够修改多种生物的 DNA，包括植物、细菌和动物，预计未来几年对其的需求将会激增。
  • 以产品来看，寡核苷酸和合成 DNA 的市场占有率预计将在 2030 年增加。合成价格的下降以及对许多应用中使用的合成 DNA、RNA 和基因的需求不断增加，推动了这一领域的成长。
  • 从应用来看，医疗保健领域在全球市场中占有很大份额。这是由于药物筛检和药物发现的增加。此外，合成生物学的使用降低了药物发现成本并促进了市场成长。
  • 按最终用途划分，到 2024 年，生物技术和製药公司产业将占据主要份额。这是由于现代研究设施的不断增加、有利的立法以及政府的援助和资助。
  • 由于该地区研发投资高、技术先进的医疗保健研究框架的可用性以及合成生物学市场的开拓，北美将在 2024 年被定位为主导市场。
  • 由于个人化治疗的兴起和主要企业的存在，预计亚太地区在未来几年将出现可观的增长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场趋势及展望
  • 市场动态
    • 扩大合成生物学的应用
    • 政府和私人组织增加资金和支持
    • 扩大合成生物学的研发活动
  • 市场限制因素分析
    • 生物安全和生物安保问题
    • 道德问题和意外后果
  • 产业分析工具
    • SWOT 分析；按因素（政治/法律、经济/技术）
    • 波特五力分析
    • COVID-19 影响分析

第四章 产品经营分析

  • 产品细分仪表板
  • 全球合成生物市场：产品变异分析
  • 2018-2030年全球合成生物学市场规模及趋势分析（依产品）
  • 寡核苷酸/寡核苷酸丛集和合成 DNA
    • 寡核苷酸/寡核苷酸丛集和合成 DNA 市场，2018-2030
  • 酵素
    • 酵素市场，2018-2030
  • 克隆技术套件
    • 克隆技术套件市场，2018-2030
  • 异源核酸
    • 异源核酸市场，2018-2030
  • 底盘有机体
    • 底盘机体市场，2018-2030

第五章技术商业分析

  • 技术细分仪表板
  • 全球合成生物学市场：技术波动分析
  • 2018-2030 年全球合成生物学市场规模与趋势分析（按技术）
  • PCR
    • PCR市场，2018-2030
  • 基因组编辑
    • 基因组编辑市场，2018-2030
  • NGS
    • NGS 市场，2018-2030
  • 生物加工技术
    • 生物製程技术市场，2018-2030
  • 其他的
    • 其他市场，2018-2030

第 6 章应用程式的商业分析

  • 使用细分仪表板
  • 全球合成生物学市场：应用变迁分析
  • 2018-2030 年全球合成生物学市场规模与趋势分析（按应用）
  • 合成生物市场：技术变迁分析
  • 卫生保健
    • 医疗保健市场，2018-2030
    • 临床
    • 非临床
  • 非医疗保健
    • 非医疗保健市场，2018-2030
    • 生物技术作物
    • 特种化学品
    • 生质燃料
    • 其他的

第 7 章最终用途业务分析

  • 最终用途细分仪表板
  • 全球合成生物学市场：最终用途变化分析
  • 2018-2030 年全球合成生物学市场规模与趋势分析（依最终用途）
  • 生物技术和製药公司
    • 生物技术和製药公司市场，2018-2030
  • 学术研究所
    • 学术研究机构市场，2018-2030
  • 其他的
    • 其他市场，2018-2030

第八章区域业务分析

  • 区域仪表板
  • 2018-2030年市场规模及预测及趋势分析
  • 北美洲
    • 北美合成生物市场，2018-2030
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲合成生物学市场，2018-2030
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太合成生物市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲合成生物市场，2018-2030
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 中东和非洲合成生物学市场，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争格局

  • 参与企业
  • 策略规划
  • 2024 年企业市场分析
  • 参与企业概况
    • Bota Biosciences Inc.
    • Codexis, Inc.
    • Creative Biogene
    • Creative Enzymes
    • Enbiotix, Inc.
    • Illumina, Inc.
    • Merck KGaA
    • New England Biolabs
    • Eurofins Scientific
    • Novozymes
    • Pareto Bio, Inc.
    • Scarab Genomics, Inc.
    • Synthego
    • Synthetic Genomics Inc.
    • Thermo Fisher Scientific, Inc.
Product Code: 978-1-68038-182-5

Synthetic Biology Market Growth & Trends:

The global synthetic biology market size is expected to reach USD 42.06 billion by 2030, registering a CAGR of 17.30% 2025 to 2030, according to a new report by Grand View Research, Inc. The presence of government and private funding to support research in vaccines and a strong synthetic biologic-based product pipeline in clinical trials are the key driving factors for the market. Synthetic biology processes provide crucial advantages for producing antigen and diagnostic reagents for disease identification, accelerating the speed of vaccine development, and improving overall vaccine performance and yield.

Furthermore, support from government agencies and the presence of several programs are likely to boost the market growth. For instance, in the U.S., COVID-19 vaccine R&D, manufacture, regulation, and purchase have been highly supported by collaboration between federal agencies, including the Biomedical Advanced Research and Development Authority (BARDA), the National Institutes of Health (NIH), DOD, FDA, and others (formerly OWS).

Other factors such as expanding demand in industries such as textiles and nutrition are also contributing to the market growth. Several optimal food production processes have been identified with the help of synthetic biology. In addition, synthetic biology is predicted to aid in the generation of higher agricultural yields and pest control development. It is expected to help in the production of better food yield and pest control management.

The COVID-19 pandemic is anticipated to positively impact market growth. Synthetic biology has been highlighted as a means to accelerate vaccine development by the National Institute of Health in the U.S. Therefore, synthetic biology labs and companies have been actively utilizing this technology to combat the COVID-19 pandemic. As a result, the usage of these technologies is projected to increase during the outbreak.

The growing demand for personalized medicine is expected to majorly drive market growth during the coming years. The use of engineered novel proteins for use as therapeutics has demonstrated synthetic biology in the medical segment. These proteins are designed with some modified protein structure to get the desirable properties required for the treatment. For instance, researchers are developing a therapeutic enzyme candidate that is GI-stable and can be given via oral route to treat Phenylketonuria (PKU).

On the other hand, synthetic biology has raised a few concerns regarding biosecurity and biosafety. Exposure to these products may cause unknown hazards to public health and the environment. To prevent such issues, countries of Europe, the Americas, and Asia have formulated policies to manage the application of synthetic biology techniques in basic & applied research.

Synthetic Biology Market Report Highlights:

  • By technology, the PCR segment held the largest share of the market. This is attributed to the accelerated development in modern life science, with PCR technology being widely employed in numerous fields of medical research, virus detection, and the food & beverage industry
  • The genome-editing segment is expected to grow steadily during the forecast period. It enables researchers to modify the DNA of various organisms, including plants, bacteria, and animals, and their demand is expected to skyrocket in the coming years
  • By product, Oligonucleotide and Synthetic DNA is anticipated to have the larger market share in 2030. The falling price of synthesis and increasing requirement for synthetic DNA, RNA, and genes that are employed in numerous applications contribute to the segment growth
  • By application, the healthcare segment held a larger global market share. This is attributed to an increase in drug screening and discovery. Moreover, the use of synthetic biology can reduce the cost of drug discovery and propel market growth
  • By end-user, the biotechnology and pharmaceutical companies segment held a larger share in 2024, owing to the growing availability of modern research facilities, favorable legislation, and government assistance and funding
  • North America was positioned as the dominant market in 2024 due to the presence of high R&D investment, the availability of technologically advanced healthcare research frameworks, and the development of the synthetic biology market in the region
  • The Asia Pacific is expected to witness considerable growth in the future owing to the rising development of personalized treatment and the presence of key players

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Technology Segment
    • 1.2.3. Application Segment
    • 1.2.4. End Use Segment
  • 1.3. Information Analysis
    • 1.3.1. Market Formulation & Data Visualization
  • 1.4. Data Validation & Publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Increasing Applications of Synthetic Biology
    • 3.3.2. Growing Funding and Assistance from Government and Private Organization
    • 3.3.3. Growing Research and Development Activities in Synthetic Biology
  • 3.4. Market Restraint Analysis
    • 3.4.1. Biosafety and Biosecurity Issue
    • 3.4.2. Ethical Issues and Unintended Consequences
  • 3.5. Industry Analysis Tools
    • 3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.5.2. Porter's Five Forces Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Global Synthetic Biology Market: Product Movement Analysis
  • 4.3. Global Synthetic Biology Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Oligonucleotide/Oligo pools and Synthetic DNA
    • 4.4.1. Oligonucleotide/Oligo pools and Synthetic DNA Market, 2018 - 2030 (USD Million)
  • 4.5. Enzymes
    • 4.5.1. Enzymes Market, 2018 - 2030 (USD Million)
  • 4.6. Cloning Technologies Kits
    • 4.6.1. Cloning Technologies Kits Market, 2018 - 2030 (USD Million)
  • 4.7. Xeno-nucleic Acids
    • 4.7.1. Xeno-nucleic Acids Market, 2018 - 2030 (USD Million)
  • 4.8. Chassis Organism
    • 4.8.1. Chassis Organism Market, 2018 - 2030 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. Technology Segment Dashboard
  • 5.2. Global Synthetic Biology Market: Technology Movement Analysis
  • 5.3. Global Synthetic Biology Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 5.4. PCR
    • 5.4.1. PCR Market, 2018 - 2030 (USD Million)
  • 5.5. Genome Editing
    • 5.5.1. Genome Editing Market, 2018 - 2030 (USD Million)
  • 5.6. NGS
    • 5.6.1. NGS Market, 2018 - 2030 (USD Million)
  • 5.7. Bioprocessing Technology
    • 5.7.1. Bioprocessing Technology Market, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Global Synthetic Biology Market: Application Movement Analysis
  • 6.3. Global Synthetic Biology Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Synthetic Biology Market: Technology Movement Analysis
  • 6.5. Healthcare
    • 6.5.1. Healthcare Market, 2018 - 2030 (USD Million)
    • 6.5.2. Clinical
      • 6.5.2.1. Clinical Market, 2018 - 2030 (USD Million)
      • 6.5.2.2. Bio/Pharmaceuticals
        • 6.5.2.2.1. Bio/Pharmaceuticals Market, 2018 - 2030 (USD Million)
      • 6.5.2.3. Diagnostics
        • 6.5.2.3.1. Diagnostics Market, 2018 - 2030 (USD Million)
    • 6.5.3. Non-Clinical
      • 6.5.3.1. Non-Clinical Market, 2018 - 2030 (USD Million)
  • 6.6. Non-Healthcare
    • 6.6.1. Non-Healthcare Market, 2018 - 2030 (USD Million)
    • 6.6.2. Biotech Crops
      • 6.6.2.1. Biotech Crops Market, 2018 - 2030 (USD Million)
    • 6.6.3. Specialty Chemicals
      • 6.6.3.1. Specialty Chemicals Market, 2018 - 2030 (USD Million)
    • 6.6.4. Bio-Fuels
      • 6.6.4.1. Bio-Fuels Market, 2018 - 2030 (USD Million)
    • 6.6.5. Others
      • 6.6.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. End Use Business Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Global Synthetic Biology Market: End Use Movement Analysis
  • 7.3. Global Synthetic Biology Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Biotechnology and Pharmaceutical Companies
    • 7.4.1. Biotechnology and Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 7.5. Academic & Research Institutes
    • 7.5.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Regional Dashboard
  • 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 8.3. North America
    • 8.3.1. North America Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Target Disease Prevalence
      • 8.3.2.3. Competitive Scenario
      • 8.3.2.4. Regulatory Framework
      • 8.3.2.5. U.S. Synthetic Biology Market, 2018 - 2030 (USD MILLION)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. Canada Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Mexico Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Target Disease Prevalence
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Regulatory Framework
      • 8.4.2.5. Germany Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.4.3. UK
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. UK Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. France Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Italy Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Spain Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. Denmark Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Target Disease Prevalence
      • 8.4.8.3. Competitive Scenario
      • 8.4.8.4. Regulatory Framework
      • 8.4.8.5. Sweden Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Target Disease Prevalence
      • 8.4.9.3. Competitive Scenario
      • 8.4.9.4. Regulatory Framework
      • 8.4.9.5. Norway Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Target Disease Prevalence
      • 8.5.2.3. Competitive Scenario
      • 8.5.2.4. Regulatory Framework
      • 8.5.2.5. Japan Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. China Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. India Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Target Disease Prevalence
      • 8.5.5.3. Competitive Scenario
      • 8.5.5.4. Regulatory Framework
      • 8.5.5.5. South Korea Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Target Disease Prevalence
      • 8.5.6.3. Competitive Scenario
      • 8.5.6.4. Regulatory Framework
      • 8.5.6.5. Australia Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Target Disease Prevalence
      • 8.5.7.3. Competitive Scenario
      • 8.5.7.4. Regulatory Framework
      • 8.5.7.5. Thailand Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Target Disease Prevalence
      • 8.6.2.3. Competitive Scenario
      • 8.6.2.4. Regulatory Framework
      • 8.6.2.5. Brazil Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Argentina Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Target Disease Prevalence
      • 8.7.2.3. Competitive Scenario
      • 8.7.2.4. Regulatory Framework
      • 8.7.2.5. South Africa Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Target Disease Prevalence
      • 8.7.3.3. Competitive Scenario
      • 8.7.3.4. Regulatory Framework
      • 8.7.3.5. Saudi Arabia Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Target Disease Prevalence
      • 8.7.4.3. Competitive Scenario
      • 8.7.4.4. Regulatory Framework
      • 8.7.4.5. UAE Synthetic Biology Market, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Target Disease Prevalence
      • 8.7.5.3. Competitive Scenario
      • 8.7.5.4. Regulatory Framework
      • 8.7.5.5. Kuwait Synthetic Biology Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Participant's Overview
    • 9.4.1. Bota Biosciences Inc.
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Codexis, Inc.
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Creative Biogene
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Creative Enzymes
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Enbiotix, Inc.
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Illumina, Inc.
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Merck KGaA
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. New England Biolabs
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Eurofins Scientific
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Novozymes
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives
    • 9.4.11. Pareto Bio, Inc.
      • 9.4.11.1. Overview
      • 9.4.11.2. Financial Performance
      • 9.4.11.3. Product Benchmarking
      • 9.4.11.4. Strategic Initiatives
    • 9.4.12. Scarab Genomics, Inc.
      • 9.4.12.1. Overview
      • 9.4.12.2. Financial Performance
      • 9.4.12.3. Product Benchmarking
      • 9.4.12.4. Strategic Initiatives
    • 9.4.13. Synthego
      • 9.4.13.1. Overview
      • 9.4.13.2. Financial Performance
      • 9.4.13.3. Product Benchmarking
      • 9.4.13.4. Strategic Initiatives
    • 9.4.14. Synthetic Genomics Inc.
      • 9.4.14.1. Overview
      • 9.4.14.2. Financial Performance
      • 9.4.14.3. Product Benchmarking
      • 9.4.14.4. Strategic Initiatives
    • 9.4.15. Thermo Fisher Scientific, Inc.
      • 9.4.15.1. Overview
      • 9.4.15.2. Financial Performance
      • 9.4.15.3. Product Benchmarking
      • 9.4.15.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 4 Global Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 5 Global Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 6 Global Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 7 Global Synthetic Biology Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Synthetic Biology Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 10 North America Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 11 North America Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 12 North America Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 14 U.S. Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 15 U.S. Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 16 U.S. Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 17 Canada Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 18 Canada Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 19 Canada Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 20 Canada Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 21 Mexico Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 22 Mexico Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 23 Mexico Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 24 Mexico Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 25 Europe Synthetic Biology Market, by Country, 2018 - 2030 (USD Million)
  • Table 26 Europe Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 27 Europe Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 28 Europe Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 29 Europe Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 30 Germany Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 31 Germany Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 32 Germany Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 33 Germany Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 34 UK Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 35 UK Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 36 UK Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 37 UK Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 38 France Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 39 France Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 40 France Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 41 France Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 42 Italy Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 43 Italy Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 44 Italy Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 45 Italy Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 46 Spain Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 47 Spain Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 48 Spain Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 49 Spain Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 50 Denmark Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 51 Denmark Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 52 Denmark Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 53 Denmark Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 54 Sweden Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 55 Sweden Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 56 Sweden Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 57 Sweden Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 58 Norway Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 59 Norway Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 60 Norway Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 61 Norway Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Synthetic Biology Market, by Country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 67 China Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 68 China Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 69 China Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 70 China Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 71 Japan Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 72 Japan Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 73 Japan Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 74 Japan Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 75 India Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 76 India Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 77 India Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 78 India Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 79 South Korea Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 80 South Korea Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 81 South Korea Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 82 South Korea Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 83 Australia Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 84 Australia Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 85 Australia Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 86 Australia Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 87 Thailand Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 88 Thailand Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 89 Thailand Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 90 Thailand Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 91 Latin America Synthetic Biology Market, by Country, 2018 - 2030 (USD Million)
  • Table 92 Latin America Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 93 Latin America Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 94 Latin America Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 95 Latin America Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 96 Brazil Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 97 Brazil Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 98 Brazil Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 99 Brazil Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 100 Argentina Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 101 Argentina Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 102 Argentina Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 103 Argentina Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Synthetic Biology Market, by Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 109 South Africa Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 110 South Africa Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 111 South Africa Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 112 South Africa Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 117 UAE Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 118 UAE Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 119 UAE Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 120 UAE Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Synthetic Biology Market Segmentation
  • Fig. 7 Market Snapshot, 2024
  • Fig. 8 Market Trends & Outlook
  • Fig. 9 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Global Synthetic Biology Market: Product Key Takeaways
  • Fig. 14 Global Synthetic Biology Market: Product Movement Analysis
  • Fig. 15 Global Synthetic Biology Market, for Oligonucleotide/Oligo pools and Synthetic DNA, 2018 - 2030 (USD Million)
  • Fig. 16 Global Synthetic Biology Market, for Enzymes, 2018 - 2030 (USD Million)
  • Fig. 17 Global Synthetic Biology Market, for Cloning Technologies Kits, 2018 - 2030 (USD Million)
  • Fig. 18 Global Synthetic Biology Market, for Xeno-nucleic acids, 2018 - 2030 (USD Million)
  • Fig. 19 Global Synthetic Biology Market, for Chassis Organism, 2018 - 2030 (USD Million)
  • Fig. 20 Global Synthetic Biology Market: Technology Key Takeaways
  • Fig. 21 Global Synthetic Biology Market: Technology Movement Analysis
  • Fig. 22 Global Synthetic Biology Market, for PCR, 2018 - 2030 (USD Million)
  • Fig. 23 Global Synthetic Biology Market, for Genome Editing, 2018 - 2030 (USD Million)
  • Fig. 24 Global Synthetic Biology Market, for NGS, 2018 - 2030 (USD Million)
  • Fig. 25 Global Synthetic Biology Market, for Bioprocessing Technology, 2018 - 2030 (USD Million)
  • Fig. 26 Global Synthetic Biology Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 27 Global Synthetic Biology Market: Application Key Takeaways
  • Fig. 28 Global Synthetic Biology Market, Application Movement Analysis
  • Fig. 29 Global Synthetic Biology Market, for Healthcare, 2018 - 2030 (USD Million)
  • Fig. 30 Global Synthetic Biology Market, for Clinical, 2018 - 2030 (USD Million)
  • Fig. 31 Global Synthetic Biology Market, for Bio/Pharmaceuticals, 2018 - 2030 (USD Million)
  • Fig. 32 Global Synthetic Biology Market, for Diagnostics, 2018 - 2030 (USD Million)
  • Fig. 33 Global Synthetic Biology Market, for Non-Clinical, 2018 - 2030 (USD Million)
  • Fig. 34 Global Synthetic Biology Market, for Non-Healthcare, 2018 - 2030 (USD Million)
  • Fig. 35 Global Synthetic Biology Market, for Biotech Crops, 2018 - 2030 (USD Million)
  • Fig. 36 Global Synthetic Biology Market, for Specialty Chemiclas, 2018 - 2030 (USD Million)
  • Fig. 37 Global Synthetic Biology Market, for Bio-fuels, 2018 - 2030 (USD Million)
  • Fig. 38 Global Synthetic Biology Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 39 Global Synthetic Biology Market: End Use Movement Analysis
  • Fig. 40 Global Synthetic Biology Market, for Biotechnology and Pharmaceutical Companies, 2018 - 2030 (USD Million)
  • Fig. 41 Global Synthetic Biology Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
  • Fig. 42 Global Synthetic Biology Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 43 Regional Marketplace: Key Takeaways
  • Fig. 44 Regional Outlook, 2024 & 2030
  • Fig. 45 North America Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 47 Canada Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 48 Mexico Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 49 Europe Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 50 Germany Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 51 UK Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 52 France Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 53 Italy Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 54 Spain Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 55 Denmark Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 56 Sweden Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 57 Norway Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 59 Japan Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 60 China Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 61 India Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 62 Australia Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 66 Brazil Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 67 Argentina Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 68 Middle East and Africa Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 69 South Africa Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 70 Saudi Arabia Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 71 UAE Synthetic Biology Market, 2018 - 2030 (USD Million)
  • Fig. 72 Kuwait Synthetic Biology Market, 2018 - 2030 (USD Million)